A3P Digitalization

Forum A3P Spain

A3P Digitalization

Cuando?

18 de noviembre de 2025

Donde?

Renaissance Barcelona Fira Hotel

Barcelona, España


Formato?

Conferencias, Exposición, Talleres de partners, Mesa redonda

Introducción

Esta jornada A3P reunirá a expertos industriales del sector farmacéutico para explorar los retos y oportunidades de la digitalización.
Un día dedicado a profundizar sobre las claves regulatorias del Anexo 11, así como a profundas sesiones sobre la revisión de alarmas, la digitalización de la terapia celular y la automatización de almacén.
Además, contaremos con una mesa redonda para analizar las sinergias y casos de uso emergentes.
Este evento plantea un enfoque riguroso y práctico, ideal para equipos de calidad, producción e ingeniería que buscan comprender y adoptar estrategias digitales innovadoras.
Otra jornada intensa para compartir experiencias, debatir soluciones y seguir construyendo juntos la industria 4.0 farmacéutica.

Idioma oficial de las conferencias : Español 🇪🇸
Traducción simultánea : Inglés 🇬🇧
PARTICIPANTE
EXPOSICIÓN

PROGRAMA

Artículos relacionados

Digitalization in cleaning validation an overview of possibilities, challenges, and opportunities for savings?

La Vague 83 / Octubre 2024
Within the pharmaceutical industry, there has been a significant surge in articles and publications related to digitalization, with abundant references to concepts such as Pharma 4.0. This article intends to shine a spotlight on the ongoing discussions surrounding digitalization within the realms of cleaning validation, overall hygiene protocols, and adjacent quality assurance activities...
Button

What does 21 CFR Part 11 mean in everyday online analytics?

La Vague 83 / Octubre 2024
The article highlights some details how FDA 21 CFR Part 11 and EU Annex 11 shall be implemented and can be “lived” effectively. By reaching compliance more easily, operational efficiency is enhanced, and costs are lowered. You (The customer) is given peace-of-mind. The article gives answers to some key questions like “Can I fulfill 21 CFR Part 11 easily?” and “How do I reach data integrity?”
Button

Key Allies in Preventing Contaminants and Impurities in Bioproduction

In the biopharmaceutical industry, the prevention of microbial contaminants and the control of process related impurities are critical requirements to ensure patient safety, therapeutic efficacy, and regulatory compliance. As processes become more complex and regulatory expectations intensify, Blow-Fill-Seal (BFS) and Single-Use Systems (SUS) technologies are emerging as key solutions to strengthen risk management. By minimizing potential entry points for contaminants and streamlining production flows, these innovations address the industry’s demands for robustness, traceability, and responsiveness.
a3p.org